Veerle Goosens
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Veerle Goosens has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Frederik Maes
KU Leuven
3 shared publications - Kristl G. Claeys
Department of Neurology University Hospitals Leuven Leuven Belgium
3 shared publications - Lotte Huysmans
Department ESAT/PSI, KU Leuven, Belgium
3 shared publications - Louise Iterbeke
Laboratory for Muscle Diseases and Neuropathies, Department of Neurosciences, KU Leuven, and Leuven Brain Institute (LBI) and Leuven Institute for Rare Diseases (Leuven.IRD), Belgium
3 shared publications - Patrick Dupont
Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, and Leuven Brain Institute (LBI), Belgium; and
3 shared publications - Ronald Peeters
Department of Radiology, University Hospitals Leuven, Belgium
3 shared publications
Latest Publications
- 22 December 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (12)
Quantifying Disease Progression in Patients With Charcot-Marie-Tooth Neuropathy Type 1A Using Quantitative Muscle MRI and Clinical Outcomes
- 22 December 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (12)
Quantifying Disease Progression in Patients With Charcot-Marie-Tooth Neuropathy Type 1A Using Quantitative Muscle MRI and Clinical Outcomes
- Open Access
- 25 August 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (4) , e218411
Quantifying Disease Progression in Patients With Charcot-Marie-Tooth Neuropathy Type 1A Using Quantitative Muscle MRI and Clinical Outcomes
Background and ObjectivesCharcot-Marie-Tooth neuropathy type 1A (CMT1A) is a slowly progressive demyelinating neuropathy with distal muscle weakness and atrophy. Sensitive, objective outcome measur...
- 25 August 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (4) , e218411
Open AccessQuantifying Disease Progression in Patients With Charcot-Marie-Tooth Neuropathy Type 1A Using Quantitative Muscle MRI and Clinical Outcomes
Background and ObjectivesCharcot-Marie-Tooth neuropathy type 1A (CMT1A) is a slowly progressive demyelinating neuropathy with distal muscle weakness and atrophy. Sensitive, objective outcome measur...
- Open Access
- 25 August 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (4) , e218349
Natural History of Adult-Onset Myotonic Dystrophy Type 1
Background and ObjectivesAdult-onset myotonic dystrophy type 1 (DM1) is a progressive, multisystemic disorder, characterized by distal muscle weakness and myotonia. As disease-modifying therapies e...
- 25 August 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (4) , e218349
Open AccessNatural History of Adult-Onset Myotonic Dystrophy Type 1
Background and ObjectivesAdult-onset myotonic dystrophy type 1 (DM1) is a progressive, multisystemic disorder, characterized by distal muscle weakness and myotonia. As disease-modifying therapies e...